# Pub. L. 117-167: changes to the Internal Revenue Code

2022-08-09, 136 Stat. 1398. Source: <https://www.govinfo.gov/link/plaw/117/public/167>.

## Legislative history

- Bill: [H.R. 4346](https://www.congress.gov/bill/117th-congress/house-bill/4346)
- House report: [H. Rept. 117-80](https://www.govinfo.gov/content/pkg/CRPT-117hrpt80/html/CRPT-117hrpt80.htm)
- Bluebook: [JCT general explanation (2023)](https://www.govinfo.gov/app/details/CPRT-117JPRT53965)

## § 46: Amount of credit

- § 46(6): Pub. L. 117–167 amended par. (6) generally. Prior to amendment, text read as follows: “the qualifying therapeutic discovery project credit.”

## § 48D: Advanced manufacturing investment credit

- Enacted 26 U.S.C. § 48D.

## § 49: At-risk rules

- § 49(a)(1)(C)(vi): Pub. L. 117–167 added cl. (vi).

## § 50: Other special rules

- § 50(a)(2)(E): Pub. L. 117–167, § 107(d)(3), substituted “48C(b)(2), or 48D(b)(5)” for “or 48C(b)(2)”.
- § 50(a)(3): Pub. L. 117–167, § 107(b)(1), added par. (3). Former par. (3) redesignated (4).
- § 50(a)(4): Pub. L. 117–167, § 107(b)(3)(A)(ii), inserted “or applicable transaction” before period at end.
- § 50(a)(4): Pub. L. 117–167, § 107(b)(3)(A)(i), which directed the insertion of “, or any applicable transaction to which paragraph (3)(A) applies” after “paragraphs (1) and (2)”, was executed by making the insertion after “paragraph (1) or (2)” to reflect the probable intent of Congress.
- § 50(a)(4): Pub. L. 117–167, § 107(b)(1), redesignated par. (3) as (4). Former par. (4) redesignated (5).
- § 50(a)(5), § 50(a)(6): Pub. L. 117–167, § 107(b)(1), redesignated pars. (4) and (5) as (5) and (6), respectively.
- § 50(a)(6): Pub. L. 117–167, § 107(b)(3)(B), substituted “paragraph (1), (2), or (3)” for “paragraph (1) or (2)”.
- § 50(a)(6): Pub. L. 117–167, § 107(b)(2), added subpars. (D) and (E).

## § 1371: Coordination with subchapter C

- § 1371(d)(1): Pub. L. 117–167 substituted “section 50(a)(5)” for “section 50(a)(4)”.